Impact of a ketogenic diet on sleep quality in people with relapsing multiple sclerosis

被引:1
作者
Perlman, Jacob [1 ]
Wetmore, Emma [1 ,2 ]
Lehner-Gulotta, Diana [3 ]
Banwell, Brenda [4 ]
Bergqvist, A. G. Christina [4 ]
Coleman, Rachael [1 ]
Chen, Shanshan [5 ]
Conaway, Mark [6 ]
Goldman, Myla D. [7 ]
Morse, Anne Marie [8 ]
Brenton, J. Nicholas [3 ]
机构
[1] Univ Virginia, Dept Neurol, Charlottesville, VA USA
[2] Med Univ South Carolina, Sch Med, Charleston, SC USA
[3] Univ Virginia, Dept Neurol, Div Child Neurol, POB 800394, Charlottesville, VA 22908 USA
[4] Univ Penn, Childrens Hosp Philadelphia, Dept Neurol & Pediat, Div Child Neurol,Perelman Sch Med, Philadelphia, PA USA
[5] Virginia Commonwealth Univ, Dept Publ Hlth Sci, Richmond, VA USA
[6] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA USA
[7] Virginia Commonwealth Univ, Dept Neurol, Richmond, VA USA
[8] Janet Weis Childrens Hosp, Geisinger Med Ctr, Div Child Neurol & Pediat Sleep Med, Danville, PA USA
基金
美国国家卫生研究院;
关键词
Diet; Obesity; Sleep; Apnea; Insomnia; Restless leg; BETA-HYDROXYBUTYRATE; DAYTIME SLEEPINESS; POOR SLEEP; FATIGUE; SCALE; PREVALENCE; HEALTH;
D O I
10.1016/j.sleep.2024.08.020
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Sleep disturbance in MS is common and can significantly impair overall quality of life. The ketogenic diet (KD) associates with improved sleep quality in people living with epilepsy and may have similar benefits when used within MS; however, the impact of a KD on sleep in this population remains poorly defined. Methods: Forty-five patients with relapsing MS enrolled into a 6-month KD intervention trial and completed selfreported assessments of sleep quality and sleep disorder symptoms prior to diet initiation and while on diet, using the Epworth Sleepiness Scale (ESS) and Sleep Disorders Symptom Checklist-25 (SDS). Participants who did not complete sleep assessments at baseline and 6-months were excluded from analysis. In addition to sleep metrics, data collection included anthropometrics and MS-related fatigue scores. Results: Thirty-nine of 45 (87 %) participants completed the required sleep assessments. There was a mean reduction in ESS score of 1.90 (95 % CI [-2.85, -0.94], p < 0.001). Total SDS score decreased at 6-months on KD (-4.4, 95 % CI [-7.1, -1.7], p = 0.002), with improvements noted in insomnia (-1.55, 95 % CI [-2.66, -0.43], p = 0.008), obstructive sleep apnea (-0.91, 95 % CI [-1.57, -0.25], p = 0.008), and restless leg syndrome screening scores (-1.00, 95 % CI [-1.95, -0.051], p = 0.04). Sleep duration was unchanged on KD. Conclusion: KD associates with improvements in daytime sleepiness, independent of sleep duration, and common comorbid sleep disorders in people living with relapsing MS. The findings herein support the benefits of KD on sleep quality and highlight the potential role of dietary therapeutics for sleep disorders in neurological disease. Trial registration information: Registered on Clinicaltrials.gov under registration number NCT03718247, posted on Oct 24, 2018. First patient enrollment date: Nov 1, 2018. Link: https://clinicaltrials.gov/ct2/show/NCT03718 247?term=NCT03718247&draw=2&rank=1.
引用
收藏
页码:213 / 220
页数:8
相关论文
共 45 条
  • [1] β-Hydroxybutyrate in the Brain: One Molecule, Multiple Mechanisms
    Achanta, Lavanya B.
    Rae, Caroline D.
    [J]. NEUROCHEMICAL RESEARCH, 2017, 42 (01) : 35 - 49
  • [2] Acute effects of the very low carbohydrate diet on sleep indices
    Afaghi, Ahmad
    O'Connor, Helen
    Chow, Chin Moi
    [J]. NUTRITIONAL NEUROSCIENCE, 2008, 11 (04) : 146 - 154
  • [3] Agresti A., 2013, Categorical Data Analysis, V3rd, DOI DOI 10.1002/0471249688
  • [4] Ketogenic Diets Alter the Gut Microbiome Resulting in Decreased Intestinal Th17 Cells
    Ang, Qi Yan
    Alexander, Margaret
    Newman, John C.
    Tian, Yuan
    Cai, Jingwei
    Upadhyay, Vaibhav
    Turnbaugh, Jessie A.
    Verdin, Eric
    Hall, Kevin D.
    Leibel, Rudolph L.
    Ravussin, Eric
    Rosenbaum, Michael
    Patterson, Andrew D.
    Turnbaugh, Peter J.
    [J]. CELL, 2020, 181 (06) : 1263 - +
  • [5] To eat or to sleep: That is a lateral hypothalamic question
    Arrigoni, Elda
    Chee, Melissa J. S.
    Fuller, Patrick M.
    [J]. NEUROPHARMACOLOGY, 2019, 154 : 34 - 49
  • [6] AN INVENTORY FOR MEASURING DEPRESSION
    BECK, AT
    ERBAUGH, J
    WARD, CH
    MOCK, J
    MENDELSOHN, M
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 1961, 4 (06) : 561 - &
  • [7] THE SLEEP-IMMUNE CROSSTALK IN HEALTH AND DISEASE
    Besedovsky, Luciana
    Lange, Tanja
    Haack, Monika
    [J]. PHYSIOLOGICAL REVIEWS, 2019, 99 (03) : 1325 - 1380
  • [8] Sleep disturbance and fatigue in multiple sclerosis: A systematic review and meta-analysis
    Bhattarai, Jagriti Jackie
    Patel, Krina S.
    Dunn, Katherine M.
    Brown, Aeysha
    Opelt, Brett
    Hughes, Abbey J.
    [J]. MULTIPLE SCLEROSIS JOURNAL-EXPERIMENTAL TRANSLATIONAL AND CLINICAL, 2023, 9 (03)
  • [9] Impact of Dietary Intervention on Serum Neurofilament Light Chain in Multiple Sclerosis
    Bock, Markus
    Steffen, Falk
    Zipp, Frauke
    Bittner, Stefan
    [J]. NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2022, 9 (01):
  • [10] Sleep disorders in patients with multiple sclerosis
    Brass, Steven D.
    Duquette, Pierre
    Proulx-Therrien, Joelle
    Auerbach, Sanford
    [J]. SLEEP MEDICINE REVIEWS, 2010, 14 (02) : 121 - 129